mission. Early that day, she complained of an acute right earache, nausea, fever and chills. Her condition worsened rapidly. The patient was brought to her community hospital the following night (March 15, 1995) because of altered consciousness. The patient had experienced several episodes of otitis in childhood but had no other significant medical history.
On examination, the patient was stuporous. Pulse was 120 beats/min, blood pressure 120/70 mmHg, respirations 24/min and temperature 39.8°C. Examination of the head and neck was notable for marked nuchal rigidity. Neurological examination revealed a stuporous woman who moved all four limbs equally and withdrew to painful stimulus. No focal neurological deficits or cranial nerve abnormalities were discernable. The remainder of the physical examination was normal.
Lumbar puncture yielded cloudy cerebrospinal fluid (CSF) with 0.02x10 12 erythrocytes and 14.5x10 9 leukocytes/mm 3 (97% polymorphonuclear cells), glucose 0.1 mmol/L (normal range 2.2 to 3.9) and protein 4.4 g/L (0.15 to 0.45). Gram stain of spinal fluid revealed the presence of Gram-positive diplococci. Therapy with penicillin G 24 million U/day was begun immediately after lumbar puncture on the first hospital day. S pneumoniae was isolated from the blood and the CSF. Combination therapy with vancomycin 2 g/day and cefotaxime 9g/day was substituted 32 h after admission when initial susceptibility results performed on the isolate showed that the S pneumoniae was resistant to the 1 mg oxacillin disk.
At her family's request, the patient was transferred to the authors' institution on the evening of the third hospital day (March 17, 1995) . She was intubated before transportation to protect her airways. On admission, she was still stuporous but moved all limbs spontaneously. Computed tomography (CT) of the head did not reveal any intracranial lesions but showed images compatible with mild bilateral maxillary and ethmoidal sinusitis. On March 19, the lumbar puncture was repeated. Examination of the slightly cloudy fluid revealed the following results: 0.00061x10 12 erythrocytes, 0.132x10 9 leukocytes (58% polymorphonuclear), protein 1.37 g/L and glucose 4.9 mmol/L. The Gram stain was negative but six colonies of S pneumoniae grew on chocolate agar plate. By the following day, the patient had become more alert, fever was down to 38°C and nuchal rigidity was improved. The lumbar puncture was repeated on March 22. The spinal fluid was clear and results of analyses were as follows: 0.071x10 9 leukocytes (25% neutrophils), glucose 2.4 mmol/L, protein 1.04 g/L and negative culture. The patient's overall condition continued to improve over the next several days with complete recovery of consciousness. However, on March 23, the fever rose to 39°C and the patient had an episode suggestive of a seizure. A repeat CT scan of the head, glucoheptonate cerebral scintigraphy and electroencephalography did not reveal any focal lesions. A CT scan of the mastoids showed signs of chronic inflammation. An ear, nose and throat evaluation confirmed the presence of hypoacousia of the left ear attributed to old middle ear infections. There were no signs of acute otitis or mastoiditis. The fever persisted and a rash developed on March 27. On March 28, cefotaxime and vancomycin were stopped because of these cutaneous manifestations and imipenem was substi-tuted to complete 21 days of antibiotic therapy. The patient recuperated completely, the fever abated and she was discharged home.
MICROBIOLOGY
Blood culture and CSF isolates of S pneumoniae were identified according to standard methods. Susceptibility testing was performed by the microbroth dilution method as described in National Committee for Clinical Laboratory Standards (NCCLS) standard M7-A3 (9) .
The MICs as determined by the NCCLS broth microdilution method were 2 mg/L for penicillin G, 1 mg/L for cefotaxime and 0.12 mg/L for imipenem. The S pneumoniae isolate belonged to serogroup 9 (National Centre for Streptococci, Edmonton, Alberta).
DISCUSSION
In the United States, the incidence of pneumococcal meningitis is estimated at 1.1/100,000 population with a case fatality rate of 19% (2) . In spite of appropriate treatment, 30% of patients suffer from long term disabilities, mainly hearing loss. Until recently, penicillin has been the antimicrobial agent of choice for the treatment of pneumococcal meningitis. However, empirical treatment for these infections may have to be modified.
Surveillance data from the Centers for Diseases Control and Prevention in Atlanta, Georgia have shown that high level resistance to penicillin has increased more than 60-fold in the past decade, from 0.02% during the period 1979-87, to 1.3% in 1992 (10) . A study done in Toronto found the prevalence of penicillin-resistant pneumococci (PRSP) at 7.3% with highlevel resistance estimated at 1.9% in 1993-94 (4), a marked increase compared with results obtained in a 1988 study (11) . Previous data for Quebec have indicated a prevalence of less than 4% for these strains (12) , and it may be increasing (13) . In Canada, only a few cases of serious pneumococcal disease caused by strains with reduced susceptibilities to penicillin have been reported. Three Canadian reports on serious infections caused by high-level penicillin-resistant S pneumoniae have involved two infants and one five-year-old child (5) (6) (7) .
The management of PRSP meningitis is becoming increasingly difficult. Some PRSP are also resistant or intermediate (MIC 1 mg/L) to the extended spectrum cephalosporins commonly used for the empirical therapy of meningitis, with treatment failures reported (1, 14, 15) . Cephalosporins and vancomycin serve as alternative therapeutic agents in infections with pneumococcal isolates intermediate or resistant to penicillin (1, 14, 16, 17) . Vancomycin should be added when highly resistant strains are suspected or isolated. Our patient was initially treated with penicillin, and therapy with cefotaxime and vancomycin was substituted 32 h later when the initial susceptibility report indicated resistance to the oxacillin disk. She fortunately recovered completely. This clearly establishes the importance of rapid susceptibility testing methods. In view of the recent surveillance data, however, initial empirical therapy with vancomycin and a third-generation cephalosporin (cefotaxime or ceftriaxone) would have been optimal.
It is recommended that the response of any patient with PRSP meningitis be monitored by repeat examination and culture of the CSF because vancomycin treatment failures have been reported (1, 15, 16) . Possible explanations for treatment failures include the use of a low dose of vancomycin, highly variable vancomycin concentration in the CSF and the concomitant use of dexamethasone (16) . In the event that the patient's clinical condition has worsened or that the follow-up CSF examination is unsatisfactory, it is recommended that the treatment be modified based on in vitro susceptibility results. Alternative therapeutic options include rifampin, chloramphenicol if the minimal bactericidal concentration is less than 4 mg/L, and imipenem, although it has the potential risk of drug-related seizures (1, 16) . Our patient's second CSF specimen was still culture-positive after 48 h of cefotaxime and vancomycin treatment but there were definite improvements in cytology and biochemical markers and a significant reduction in the number of organisms.
A wide variety of serotypes have been associated with re-sistant isolates, including 6B, 23F, 14, 9V, 19A, 19F, and for some of these, studies have provided evidence for intercontinental spread of drug-resistant clones (10) . Of interest, all these serotypes are included in the available 23-valent vaccine. Although pneumococcal immunization could prevent serious infections, used according to the actual guidelines (18) , the vaccine would not have been administered to our patient.
CONCLUSIONS
The prevalence of penicillin and cephalosporin-resistant strains of S pneumoniae is low in Canada but increasing. The present case of meningitis in an adult caused by a highly penicillin-resistant, cefotaxime-intermediate S pneumoniae emphasizes the importance of rapid and accurate susceptibility testing methods and results, and continued surveillance of resistance patterns for both penicillin and third-generation cephalosporins. The emergence of penicillin-resistant S pneumoniae has major clinical and public health implications. At present, vancomycin and cefotaxime or ceftriaxone should be prescribed as initial empirical therapy for suspected pneumococcal meningitis.
